(Q33339949)

25 July 2017

title

Ticlopidine-Associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity (English)

1 reference

thrombotic thrombocytopenic purpura

25 July 2017

1 reference

1 reference

Y Sugio

1

1 reference

25 July 2017

T Okamura

2

1 reference

25 July 2017

K Shimoda

3

1 reference

25 July 2017

M Matsumoto

4

1 reference

25 July 2017

H Yagi

5

1 reference

25 July 2017

H Ishizashi

6

1 reference

25 July 2017

Y Niho

7

1 reference

25 July 2017

S Inaba

8

1 reference

25 July 2017

Y Fujimura

9

1 reference

25 July 2017

publication date

1 October 2001

1 reference

International Journal of Hematology

25 July 2017

published in

1 reference

25 July 2017

volume

74

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

347-351

1 reference

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

25 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02982073

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02982073

Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura

21 January 2018

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

12 December 2020

Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).

1 reference

12 December 2020

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation

1 reference

12 December 2020

Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting

1 reference

12 December 2020

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

12 December 2020

Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets

1 reference

12 December 2020

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

12 December 2020

Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02982073

1 reference

Dimensions Publication ID

25 July 2017

1033265839

0 references

1 reference